People were impressed with $RCGP because of "Ray Grimm". While Mr. Grimm is impressive -- he's one man and he hasn't been part of Big Pharma. ;)
If $RCGP was able to run to $1.6 Billion market cap as a start-up without current SEC filings... I would sure as hell hope $NXEN can run beyond $500M after their CSE cross-list and some updates related to their drug research & development. Especially when their Annual Report talked about FDA communication already.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.